SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-049255
Filing Date
2021-02-22
Accepted
2021-02-19 19:13:52
Documents
1
Group Members
3X5 RIVERVEST FUND II, L.P.3X5 RIVERVEST FUND II-B, L.P.3X5 RIVERVEST PARTNERS II, LLCJAY SCHMELTERJOHN P. MCKEARN, PH.D.RIVERVEST 3X5 MANAGERS II, L.P.RIVERVEST 3X5 MANAGERS II, LLCRIVERVEST VENTURE FUND II (OHIO), L.P.RIVERVEST VENTURE FUND II, L.P.RIVE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d80897dsc13da.htm SC 13D/A 378985
  Complete submission text file 0001193125-21-049255.txt   381283
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Subject) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90578 | Film No.: 21657785
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105
Business Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105 314-726-6700
RiverVest Venture Fund III, L.P. (Filed by) CIK: 0001601559 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A